The report on Neuromodulation Market by Infinium Global Research analyzes over the period of 2016 to 2022. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Neuromodulation Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Neuromodulation Market.
The market for global neuromodulation devices was valued at around USD 3.5 billion in 2015 and is expected to reach USD 6.5 billion by 2022, growing at a CAGR of around 9.3% during the forecast period of 2016 to 2022. Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous systems, the autonomic nervous system, and the deep cell nuclei of the brain, resulting in modulation of their activity. Neuromodulation includes several modalities, and is a cross-disciplinary approach to pain control and neurologic dysfunction. Neuromodulation can be used to treat movement disorders, spasticity, and epilepsy, as well as pain syndromes. Devices are implanted which can either include drug delivery pumps or neural stimulators.
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/149
The most common type is spinal cord stimulation, which is used for back or lower extremity pain. Spinal cord stimulation involves electrical stimulation of the spinal cord to interrupt pain signals from the spinal cord to the brain, and to trade a painful sensation with a more pleasant tingling sensation. The technology has been present since the 1960s and in the past decade has become highly effective in the treatment of pain. In addition to chronic pain relief, other neuromodulation treatments now used include deep brain stimulation for essential tremor, Parkinson’s disease, dystonia, epilepsy and disorders such as depression, obsessive compulsive disorder and Tourette syndrome; sacral nerve stimulation for pelvic disorders and incontinence; gastric and colonic stimulation for gastrointestinal disorders such as dysmotility or obesity; vagus nerve stimulation for epilepsy, obesity or depression; carotid artery stimulation for hypertension; and spinal cord stimulation for ischemic disease such as angina and peripheral vascular disease.
Company profiles
• Medtronic plc
• Boston Scientific Corporation
• St. Jude Medical
• Cyberonics
• Cochlear Ltd.
• Advanced Bionics
• Sonova Group
• Nevro Corporation
• Neuronetics, Inc.
• Greatbatch
Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/149
Key topics covered:
1. Scope of the report
2 Executive summary
3 Qualitative analysis
4 Global neuromodulation markets, by technology, 2015 – 2022
5 Global neuromodulation markets, by application, 2015 – 2022
6 Global neuromodulation markets, by geography, 2015 – 2022
7 Company profiles
Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_neuromodulation_market